Development and tolerance of natural killer cells

Current Opinion in Immunology

Volumn 11, Issue 2, 1999, Pages 129-134

  Raulet, David H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; MAJOR HISTOCOMPATIBILITY ANTIGEN; RECEPTOR;

CELL DIFFERENTIATION; CELL MATURATION; CLONAL ANERGY; FETUS BLOOD; HUMAN; IMMUNOLOGICAL TOLERANCE; MODULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; REVIEW; STEM CELL; T LYMPHOCYTE;

EID: 0033118750     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)80023-5     Document Type: Article

References (51)

1. Trinchieri G: Biology of natural killer cells. Adv Immunol 1989, 47:187-376.
2. Lanier LL: NK cell receptors. Annu Rev Immunol 1998, 16:359-393.
3. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L: Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 1996, 14:619-648.
4. Ljunggren HG, Karre K: In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990, 11:237-244.
5. Rodewald HR, Moingeon P, Lucich JL, Dosiou C, Lopez P, Reinherz EL: A population of early fetal thymocytes expressing Fc gamma RII/III contains precursors of T lymphocytes and natural killer cells. Cell 1992, 69:139-150.
6. Carlyle JR, Michie AM, Cho SK, Zúñiga-Pflücker JC: Natural killer cell development and function precede alpha beta T cell differentiation in mouse fetal thymic ontogeny. J Immunol 1998, 160:744-753.
7. Carlyle JR, Michie AM, Furlonger C, Nakano T, Lenardo MJ, Paige CJ, Zúñiga-Pflücker JC: Identification of a novel developmental stage marking lineage commitment of progenitor thymocytes. J Exp Med 1997, 186:173-182.
8. Poggi A, Costa P, Morelli L, Cantoni C, Pella N, Spada F, Biassoni R, Nanni L, Revello V, Tomasello E et al.: Expression of human NKRP1A by CD34+ immature thymocytes: NKRP1A-mediated regulation of proliferation and cytolytic activity. Eur J Immunol 1996, 26:1266-1272.
9. Rodewald HR, Kretzschmar K, Takeda S, Hohl C, Dessing M: Identification of pro-thymocytes in murine fetal blood: T lineage commitment can precede thymus colonization. EMBO J 1994, 13:4229-4240.
10. + population in the fetal blood, capable of differentiating into NK cells or T cells but not into B cells or myeloid cells. The authors propose that restriction of this bipotent progenitor cell to the T cell fate requires the thymus.
11. Moore T, Bennett M, Kumar V: Transplantable NK cell progenitors in murine bone marrow. J Immunol 1995, 154:1653-1663.
12. Kündig TM, Schorle H, Bachmann MF, Hengartner H, Zinkernagel RM, Horak I: Immune responses in interleukin-2-deficient mice. Science 1993, 262:1059-1061.
13. DiSanto JP, Müller W, Guy-Grand D, Fischer A, Rajewsky K: Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci USA 1995, 92:377-381.
14. -/- mice, the results implicate IL-15 in NK cell development.
15. Mrózek E, Anderson P, Caligiuri MA: Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood 1996, 87:2632-2640.
16. Jaleco AC, Blom B, Res P, Weijer K, Lanier LL, Phillips JH, Spits H: Fetal liver contains committed NK progenitors, but is not a site for development of CD34+ cells into T cells. J Immunol 1997, 159:694-702.
17. - cells with NK cytolytic activity. No expression of Ly49 receptors was observed but the NK cells nevertheless preferentially killed class-I-deficient cells, implicating a non-Ly49 inhibitory-receptor family.
18. Duncan GS, Mittrücker HW, Kägi D, Matsuyama T, Mak TW: The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J Exp Med 1996, 184:2043-2048.
19. -/- mice.
20. Ohteki T, Yoshida H, Matsuyama T, Duncan GS, Mak TW, Ohashi PS: The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/beta+ (NK1 + T) cells, natural killer cells, and intestinal intraepithelial T cells. J Exp Med 1998, 187:967-972. See annotation [19•].
21. -/- mice.
22. + cells. J Immunol 1986, 136:3124-3131.
23. Puzanov IJ, Bennett M, Kumar V: IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J Immunol 1996, 157:4282-4285.
24. Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH: Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 1996, 157:4741-4745.
25. b. J Exp Med 1998, 188:1841-1848.
26. Sivakumar PV, Bennett M, Kumar V: Fetal and neonatal NK1.1+ Ly49- cells can distinguish between major histocompatibility complex class I(hi) and class I(lo) target cells: Evidence for a Ly49-independent negative signaling receptor. Eur J Immunol 1997, 27:3100-3104.
27. Toomey JA, Shrestha S, de la Rue SA, Gays F, Robinson JH, Chrzanowska-Lightowlers ZM, Brooks CG: MHC class I expression protects target cells from lysis by Ly49-deficient fetal NK cells. Eur J Immunol 1998, 28:47-56.
28. + target cells was due to expression of CD94-NKG2A receptors. No expression of KIRs was observed.
29. Mingari MC, Ponte M, Bertone S, Schiavetti F, Vitale C, Bellomo R, Moretta A, Moretta L: HLA class I-specific inhibitory receptors in human T lymphocytes: Interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. Proc Natl Acad Sci USA 1998, 95:1172-1177.
30. - cells expressing none of the three Ly49 receptors studied, or only one of them, resulted in the expression of new Ly49 receptors on a fraction of the cells. Receptors expressed before transfer were stably expressed on essentially all the cells after transfer. The results fulfil a prediction of the 'sequential expression model' of Ly49 receptor expression, in which developing NK cells cumulatively express Ly49 receptors until successfully expressing self-MHC-specific receptors.
31. Valiante N, Uhberg M, Shilling H, Lienert-Weidenbach K, Arnett K, D'Andrea A, Phillips J, Lanier L, Parham P: Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997, 7:739-751. This paper represents a thorough analysis of MHC-specific receptor expression by large panels of randomly generated NK clones from two HLA-different individuals. The results show that human NK cells express an average of approximately five different inhibitory receptors per cell. The repertoires of the two donors differed strikingly in the way in which receptor families predominated. All the NK clones from each donor expressed an inhibitory receptor specific for autologous HLA molecules, but not necessarily for the other donor's HLA molecules.
32. Brennan J, Mager D, Jefferies W, Takei F: Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J Exp Med 1994, 180:2287-2295.
33. Mason LH, Ortaldo JR, Young HA, Kumar V, Bennett M, Anderson SK: Cloning and functional characteristics of murine LGL-1: A member of the Ly-49 gene family (Ly-49G2). J Exp Med 1995, 182:293-303.
34. Raulet DH, Held W, Correa I, Dorfman J, Wu M-F, CorraL L: Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 1997, 155:41-52.
35. Held W, Raulet DH: Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively mono-allelic. Eur J Immunol 1997, 27:2876-2884.
36. Sentman CL, Olsson MY, Karre K: Missing self recognition by natural killer cells in MHC class I transgenic mice. A 'receptor calibration' model for how effector cells adapt to self. Semin Immunol 1995, 7:109-119.
37. -/- lymphoblasts by ADCC but don't kill wild-type lymphoblasts by ADCC, demonstrating that they are susceptible to class-I-dependent inhibition. The results suggest that NK cells in class-I-deficient mice exhibit a form of anergy, independent of class-I-specific inhibition.
38. -/- mice are more sensitive to class-I-dependent inhibition - presumably due to enhanced expression of inhibitory receptors by these NK cells.
39. Olsson MY, Karre K, Sentman CL: Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand. Proc Natl Acad Sci USA 1995, 92:1649-1653.
40. Dorfman JR, Raulet DH: Major histocompatibility complex genes determine natural killer cell tolerance. Eur J Immunol 1996, 26:151-155.
41. Held W, Dorfman JR, Wu M-F, Raulet DH: Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur J Immunol 1996, 26:2286-2292.
42. Salcedo M, Diehl AD, Olsson-Alheim MY, Sundbäck J, Van Kaer L, Karre K, Ljunggren H-G: Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I deficient mice. J Immunol 1997, 158:3174-3180.
43. b is thought not to react with these receptors). Thus an education process limits usage of multiple self-specific Ly49 receptors by NK cells, consistent with the sequential expression model of NK cell education.
44. Bix M, Liao N-S, Zijlstra M, Loring J, Jaenisch R, Raulet D: Rejection of class I MHC-deficient hemopoietic cells by irradiated MHC-matched mice. Nature 1991, 349:329-331.
45. Liao N, Bix M, Zijlstra M, Jaenisch R, Raulet D: MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity. Science 1991, 253:199-202.
46. - bone marrow in chimeric mice. Proc Natl Acad Sci USA 1991, 88:10332-10336.
47. Sykes M, Harty MW, Karlhofer FM, Pearson DA, Szot G, Yokoyama W: Hematopoietic cells and radioresistant host elements influence natural killer cell differentiation. J Exp Med 1993, 178:223-229.
48. d, consistent with the notion that the downregulation of Ly49A in mice with a corresponding MHC ligand results in altered sensitivity of the NK cells to class-I-dependent inhibition.
49. - cells. The results indicate that interactions of developing NK cells with class-I-deficient cells dominantly induces tolerance to the latter cells.
50. Ohlen C, Kling G, Höglund P, Hansson M, Scangos G, Biebench C, Jay G, Karre K: Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science 1989, 246:666-668.
51. b cells. The results demonstrate that some forms of NK cell tolerance, at least, are rapidly reversible.